---
figid: PMC6280650__EMBR-19-e46935-g002
figlink: /pmc/articles/PMC6280650/figure/embr201846935-fig-0002/
number: F2
caption: Cytoplasmic chromatin DNA activates the cGAS‐STING pathway and induces type
  I IFN and senescence‐associated secretory phenotype (SASP) production, which promote
  cellular senescence. Uptake of tumor‐derived DNA may lead to activation of the cGAS‐STING
  pathway in DCs and production of type I IFN, which regulates cross‐priming of CD8+
  T cells for anti‐tumor immunity. Immune checkpoint pathways of PD‐L1/PD‐1 and B7/CTLA‐4
  negatively regulate CD8+ T cell activity killing cancer cells. Combinatory treatments
  with CDNs augment the anti‐tumor efficacy of immune checkpoint inhibitors (anti‐PD‐1,
  ‐PD‐L1, ‐CTLA4 antibodies), radiation therapy, and chemotherapy.
pmcid: PMC6280650
papertitle: Role of the cGAS–STING pathway in cancer development and oncotherapeutic
  approaches.
reftext: Li Teng Khoo, et al. EMBO Rep. 2018 Dec;19(12):e46935.
pmc_ranked_result_index: '42921'
pathway_score: 0.9386576
filename: EMBR-19-e46935-g002.jpg
figtitle: Role of the cGAS–STING pathway in cancer development and oncotherapeutic
  approaches
year: '2018'
organisms: Homo sapiens
ndex: 186fcf87-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6280650__EMBR-19-e46935-g002.html
  '@type': Dataset
  description: Cytoplasmic chromatin DNA activates the cGAS‐STING pathway and induces
    type I IFN and senescence‐associated secretory phenotype (SASP) production, which
    promote cellular senescence. Uptake of tumor‐derived DNA may lead to activation
    of the cGAS‐STING pathway in DCs and production of type I IFN, which regulates
    cross‐priming of CD8+ T cells for anti‐tumor immunity. Immune checkpoint pathways
    of PD‐L1/PD‐1 and B7/CTLA‐4 negatively regulate CD8+ T cell activity killing cancer
    cells. Combinatory treatments with CDNs augment the anti‐tumor efficacy of immune
    checkpoint inhibitors (anti‐PD‐1, ‐PD‐L1, ‐CTLA4 antibodies), radiation therapy,
    and chemotherapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TMEM173
  - TRA
  - CD8B
  - CGAS
  - IFNA1
  - TRB
  - CD8A
  - CD274
  - TRG
  - PDCD1
  - TRD
  - TCR
  - O EMBO
  - RADIATION
  - tumor
genes:
- word: STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: CGAS
  symbol: CGAS
  source: hgnc_symbol
  hgnc_symbol: CGAS
  entrez: '115004'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: O EMBO
  source: MESH
  identifier: D013481
diseases:
- word: RADIATION
  source: MESH
  identifier: D004194
- word: tumor
  source: MESH
  identifier: D009369
figid_alias: PMC6280650__F2
redirect_from: /figures/PMC6280650__F2
figtype: Figure
---
